Ovid Therapeutics Inc. (OVID)
NASDAQ·Healthcare·Biotechnology
$2.73
+1.30%
Mkt Cap $354.77M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 18, 2026 | $78.25K | $718.00K | +817.57% | -$0.10 | $0.06 | +160.00% | — | — |
| Q4 2025 Nov 12, 2025 | $62.60K | $132.00K | +110.86% | -$0.15 | -$0.17 | -13.33% | — | — |
| Q3 2025 Aug 13, 2025 | $61.33K | $6.27M | +10126.64% | -$0.16 | -$0.06 | +62.50% | — | — |
| Q2 2025 May 13, 2025 | $42.50K | $130.00K | +205.88% | -$0.14 | -$0.14 | +0.00% | — | — |
| Q1 2025 Mar 11, 2025 | $100.00K | $76.00K | -24.00% | -$0.16 | -$0.13 | +18.75% | — | — |
| Q4 2024 Nov 12, 2024 | $187.50K | $173.00K | -7.73% | -$0.19 | -$0.20 | -5.26% | — | — |
| Q3 2024 Aug 13, 2024 | $70.00K | $169.00K | +141.43% | -$0.22 | $0.12 | +154.55% | — | — |
| Q2 2024 May 14, 2024 | $60.00K | $148.00K | +146.67% | -$0.23 | -$0.17 | +26.09% | — | — |
| Q1 2024 Mar 8, 2024 | $60.00K | $141.56K | +135.94% | -$0.17 | -$0.22 | -29.41% | — | — |
| Q4 2023 Nov 3, 2023 | $60.00K | $108.97K | +81.62% | -$0.18 | -$0.16 | +11.11% | — | — |
| Q3 2023 Aug 4, 2023 | $50.00K | $75.00K | +50.00% | -$0.21 | -$0.18 | +14.29% | — | — |
| Q2 2023 May 5, 2023 | $20.00K | $66.00K | +230.00% | -$0.18 | -$0.19 | -5.56% | — | — |
| Q1 2023 Mar 13, 2023 | — | $46.28K | — | -$0.19 | -$0.16 | +15.79% | — | — |
| Q4 2022 Nov 8, 2022 | — | $11.10K | — | -$0.21 | -$0.17 | +19.05% | — | — |
| Q3 2022 Aug 9, 2022 | — | — | — | -$0.23 | -$0.21 | +8.70% | — | — |
| Q2 2022 May 10, 2022 | $1.31M | $1.45M | +10.53% | $1.17 | -$0.23 | -119.66% | — | — |
| Q1 2022 Mar 15, 2022 | — | -$416.35M | — | -$0.17 | -$0.38 | -123.53% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$0.19 | -$0.17 | +10.53% | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | -$0.15 | -$0.23 | -53.33% | — | — |
| Q2 2021 May 13, 2021 | $169.87M | $208.38M | +22.67% | $1.68 | $2.53 | +50.60% | — | — |